This site is intended only for healthcare professionals resident in the United Kingdom
Inflectra® is indicated in moderate to severe Crohn’s disease, moderate to severe ulcerative colitis, active rheumatoid arthritis, severe active ankylosing spondylitis, active progressive psoriatic arthritis, and moderate to severe plaque psoriasis
Health Canada/BIOTECanada Summit on Regulatory and Clinical Topics Related to Subsequent Entry Biologics (biosimilars). Biologicals. 2012. 40(6):517-527.